SARS-CoV-2-specific IgM screening has low sensitivity for identifying potentially infectious travellers

por Hasan, Tasnim, Lim, H. Ling, Hueston, Linda, Dwyer, Dominic E., O'Sullivan, Matthew
Publicado 2021

The utility of SARS‐CoV‐2‐specific serology in COVID‐19 diagnosis

por Hasan, Tasnim, Lim, H. Ling, Case, Jennifer, Hueston, Linda, Bag, Shopna, Dwyer, Dominic E., O'Sullivan, Matthew V.N.
Publicado 2021

Resistance Mutations in SARS-CoV-2 Delta Variant after Sotrovimab Use

por Rockett, Rebecca, Basile, Kerri, Maddocks, Susan, Fong, Winkie, Agius, Jessica E., Johnson-Mackinnon, Jessica, Arnott, Alicia, Chandra, Shona, Gall, Mailie, Draper, Jenny, Martinez, Elena, Sim, Eby M., Lee, Clement, Ngo, Christine, Ramsperger, Marc, Ginn, Andrew N., Wang, Qinning, Fennell, Michael, Ko, Danny, Lim, H. Ling, Gilroy, Nicky, O’Sullivan, Matthew V.N., Chen, Sharon C.-A., Kok, Jen, Dwyer, Dominic E., Sintchenko, Vitali
Publicado 2022